Reduced Live Birth Rates in Frozen Versus Fresh Single Cleavage Stage Embryo Transfer Cycles: A Cross -sectional Study
Overview
Authors
Affiliations
Background: Studies have suggested that embryo-endometrial developmental asynchrony caused by slow-growing embryos can be corrected by freezing the embryo and transferring it back in a subsequent cycle. Therefore, we hypothesized that live birth rates (LBR) would be higher in frozen embryo transfer (FET) compared with fresh embryo transfers.
Objective: To compare LBR between fresh and FET cycles.
Materials And Methods: A cross-sectional analysis of 10,744 single autologous embryo transfer cycles that used a single cleavage stage embryo was performed. Multivariate analysis was performed to compare LBR between FET and fresh cycles, after correcting for various confounding factors. Sub-analysis was also performed in cycles using slow embryos.
Results: Both LBR (19.13% vs 14.13%) and clinical pregnancy (22.48% vs 16.25%) rates (CPR) were higher in the fresh cycle group (p 0.00). Multivariate analysis for confounding factors also confirmed that women receiving a frozen-thawed embryo had a significantly lower LBR rate compared to those receiving a fresh embryo (OR 0.76, 95% CI 0.68-0.86, p 0.00). In the sub-analysis of 1,154 cycles using slow embryos, there was no statistical difference in LBR (6.40% vs 6.26%, p = 0.92) or CPR (8.10% vs 7.22%, p = 0.58) between the two groups.
Conclusion: This study shows a lower LBR in FET cycles when compared to fresh cycles. Our results suggest that any potential gains in LBR due to improved embryo-endometrial synchrony following FET are lost, presumably due to freeze-thaw process-related embryo damage.
Kieu V, Polyakov A, Rozen G, Lantsberg D, Stern C, Teh W Int J Reprod Biomed. 2023; 21(3):245-254.
PMID: 37122887 PMC: 10133739. DOI: 10.18502/ijrm.v21i3.13200.
Lee P, Zhou C, Li Y Reprod Biol Endocrinol. 2022; 20(1):57.
PMID: 35337338 PMC: 8957116. DOI: 10.1186/s12958-022-00922-5.
Sayed G, Al-Sawaf H, Al-Sawaf A, Saeid M, Maged A, Ibrahim I Pharmgenomics Pers Med. 2021; 14:27-38.
PMID: 33469340 PMC: 7810675. DOI: 10.2147/PGPM.S284064.